The Indian arm of South Korea’s Solco Biomedical has won FDA 510(k) clearance for the 4CIS Blue Dolphin Cage System, a lumbar interbody cage designed for KLIF procedures. The FDA cleared the device on November 6, 2026 (K252865) under product code MAX, the category for lumbar intervertebral fusion devices used with bone graft. The decision means the agency found it substantially equivalent to a device already legally sold in the United States.
Solco says Blue Dolphin may be the first KLIF (OLLIF) cage from a manufacturer based in Asia, the Middle East, Europe, Latin America or Africa to be cleared in the US.
The cage grew out of conversations in 2024 with spine surgeons A. Agarwal and Niraj Vasavada, whom Agarwal has credited as its inventor. It is already in clinical use in India, where Agarwal reported more than 250 cases by mid-2025. Blue Dolphin joins two lumbar cages the Indian unit had cleared in December 2022, the Dolphin TLIF and the Black Marlin PLIF. The parent company, founded in 1974, holds a string of earlier US clearances for spinal fixation and cervical devices.
About Solco Biomedical
Global medical & health care group with a history of 45 years Under our business philosophy, “make the world smile with health”, we’re devoted to improve the quality of life for everyone by developing high-tech medical instruments and health products based on medical R&D and clinical researches.Website: http://www.solco.co.kr
###
Legal Disclaimer:
Content published on SPINEMarketGroup (thespinemarketgroup.com) is provided for informational purposes only and on an “as is” basis, without warranties of any kind. We do not guarantee the accuracy, completeness, legality, or reliability of any information, images, videos, links, or third-party materials featured on the site. Any views or claims expressed in contributed content or press releases belong to their respective authors or sources. For copyright concerns, factual corrections, or content-related complaints, please contact us directly for review.
